Multicentre Study To Evaluate Efficacy And Safety Of Buprenorphine Transdermal Patch (Norspan) In Chronic Non-Malignant Pain Of Moderate To Severe Intensity Due To Osteoarthritis, Rheumatoid Arthritis, Lower Back Pain And Joint / Muscle Pain, When Opioid Is Needed For Analgesia
Phase of Trial: Phase IV
Latest Information Update: 30 Sep 2016
Price : $35 *
At a glance
- Drugs Buprenorphine (Primary)
- Indications Back pain; Musculoskeletal pain
- Focus Therapeutic Use
- Sponsors Mundipharma International
- 16 Aug 2016 Last checked against China Clinical Trials Register record.
- 14 Jan 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 10 Apr 2014 New source identified and integrated, China Clinical Trials Register record.